INNOVAX ND IBD -

Innovax ND IBD vaccine is recommended for active immunisation of one-day-old chicks or embryonated chicken eggs:

to reduce mortality and clinical signs caused by Newcastle Disease (ND) virus,
to prevent mortality and to reduce clinical signs and lesions of Infectious Bursal Disease (IBD) virus,
to reduce mortality, clinical signs and lesions caused by Marek’s Disease (MD) virus.

COMPOSITION OF INNOVAX ND IBD

Each dose (0,2 ml subcutaneous or 0,05 ml in ovo) of reconstituted vaccine contains:
Cell-associated live recombinant Turkey Herpes Virus (strain HVP360),
expressing the fusion protein of Newcastle Disease virus and the VP2 protein
of Infectious Bursal Disease virus: 10^3,3 – 10^4,6PFU¹.
1 PFU: plaque forming units.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

After dilution, administer:
Subcutaneous: One single injection of 0,2 ml per chick.
Do not use in conjunction with a vaccine containing a classical HVT strain
or any other HVT recombinant vaccine.

ADMINISTRATION OF INNOVAX ND IBD

The vaccine is administered via injection. For subcutaneous vaccination,
0,2 ml per chick is injected in the neck.

VACCINATION PROGRAMME FOR INNOVAX ND IBD

Vaccinate chicks in the hatchery

IMMUNITY

Onset of immunity:
ND: 4 weeks,
IBD: 2 weeks,
MD: 9 days.

Duration of immunity:
ND: 8 weeks,
IBD: 8 weeks,
MD: entire risk period

STORAGE

Ampoules (cell suspension): Store and transport frozen in liquid nitrogen (below –140 °C).
Nobilis® Diluent CA: Store below 25 °C.
Container: Store liquid nitrogen container securely in upright position in a clean, dry and well ventilated room separated from the hatching/chicken room in the hatchery

WITHDRAWAL PERIOD

Withdrawal period: 21 days after subcutaneous injection.

PRESENTATION

Glass ampoules containing 2 000 or 4 000 doses of vaccine.
Nobilis® Diluent CA is available in 200 ml, 400 ml or 800 ml.